Wealth Enhancement Advisory Services’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Buy |
96,001
+64,940
| +209% | +$845K | ﹤0.01% | 1616 |
|
|
2025
Q1 | $271K | Buy |
31,061
+2,564
| +9% | +$22.4K | ﹤0.01% | 2506 |
|
|
2024
Q4 | $409K | Buy |
28,497
+4,545
| +19% | +$65.3K | ﹤0.01% | 2118 |
|
|
2024
Q3 | $541K | Buy |
23,952
+10,935
| +84% | +$247K | ﹤0.01% | 1768 |
|
|
2024
Q2 | $253K | Buy |
13,017
+176
| +1% | +$3.42K | ﹤0.01% | 2105 |
|
|
2024
Q1 | $482K | Sell |
12,841
-7,559
| -37% | -$284K | ﹤0.01% | 1609 |
|
|
2023
Q4 | $1.14M | Buy |
20,400
+111
| +0.5% | +$6.21K | ﹤0.01% | 1116 |
|
|
2023
Q3 | $837K | Buy |
+20,289
| New | +$837K | ﹤0.01% | 1172 |
|